Finance

Lists
Why is KRRO down ၂.၀၁%?
Dive Deeper
KRRO:NASDAQ
Korro Bio Inc
၁၂.၁၉ US$
-၂.၀၁%
(-၀.၂၅) 1D
၁၂.၁၉ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: နို ၁၉, GMT-၅ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KRRO...
Open
၁၂.၄၄ US$
High
၁၂.၇၇ US$
Low
၁၂.၀၃ US$
Mkt. cap
၁၆.၇၃ ကုဋေ
Avg. vol.
၂.၁၆ သိန်း
Volume
၁.၀၇ သိန်း
52-wk high
၁၇.၃၅ US$
52-wk low
၅.၂၀ US$
EPS
-၉.၀၆ US$
Beta
၃.၂၃
Shares outstanding
၁.၃၇ ကုဋေ
No. of employees
၅၈
Open
၁၂.၄၄ US$
High
၁၂.၇၇ US$
Low
၁၂.၀၃ US$
Mkt. cap
၁၆.၇၃ ကုဋေ
Avg. vol.
၂.၁၆ သိန်း
Volume
၁.၀၇ သိန်း
52-wk high
၁၇.၃၅ US$
52-wk low
၅.၂၀ US$
EPS
-၉.၀၆ US$
Beta
၃.၂၃
Shares outstanding
၁.၃၇ ကုဋေ
No. of employees
၅၈
News stories
From web sources and news partners
Investing.com UK
Investing.com UK
·
ပြီးခဲ့သည့် ၁၅ နာရီ
Korro Bio at Jefferies Global Healthcare Conference: pipeline gains focus By Investing.com
About Korro Bio Inc
CEO-
Employees၅၈
Founded၂၀၁၄
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 6 analysts giving stock ratings to KRRO in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for KRRO in the last 3 months.
Highest
Current ၁၂.၁၉ US$
၃၀.၀၀ US$ (+၁၄၆.၁၀%)
Average
၁၉.၈၃ US$ (+၆၂.၆၇%)
Lowest
၁၀.၀၀ US$ (-၁၇.၉၇%)
Analyst
Recommendation
Action
Price target
Projected
Date
Luca Issi
RBC Capital
Hold
Maintained
၁၀.၀၀ US$
-၁၈%
11/05/2026
Yigal Nochomovitz
Citi
Buy
Reiterated
၂၁.၀၀ US$
+၇၂.၃%
11/05/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
၁၅.၀၀ US$
+၂၃.၁%
11/06/2026
Kostas Biliouris
Oppenheimer
Buy
Reiterated
၂၂.၀၀ US$
+၈၀.၅%
10/28/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
၃၀.၀၀ US$
+၁၄၆.၁%
10/06/2026
Unknown Analyst
LifeSci Capital
Buy
Maintained
၂၁.၀၀ US$
+၇၂.၃%
10/06/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
၂၂.၀၀ US$
+၈၀.၅%
10/06/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
၂၂.၀၀ US$
+၈၀.၅%
08/06/2026
William Maughan
Clear Street
Buy
Maintained
၁၈.၀၀ US$
+၄၇.၇%
08/07/2026
Myles Minter
William Blair
Buy
Maintained
-
-
08/06/2026
Keay Nakae
Chardan Capital
Buy
Reiterated
၁၅.၀၀ US$
+၂၃.၁%
08/06/2026
Catherine Novack
JonesTrading
Buy
Upgraded
၂၃.၀၀ US$
+၈၈.၇%
05/08/2026
Ryan Deschner
Raymond James
Buy
Upgraded
၂၃.၀၀ US$
+၈၈.၇%
03/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
၁.၂၉ သန်း
-
-
-
Cost of goods sold
၈.၆၀ သန်း
၁.၁၅ ကုဋေ
၁.၁၆ ကုဋေ
၁.၀၂ ကုဋေ
Cost of revenue
၈.၆၀ သန်း
၁.၁၅ ကုဋေ
၁.၁၆ ကုဋေ
၁.၀၂ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၈.၅၈ သန်း
၈.၉၁ သန်း
၈.၄၈ သန်း
၈.၂၉ သန်း
Operating expense
၈.၅၈ သန်း
၈.၉၁ သန်း
၈.၄၈ သန်း
၈.၂၉ သန်း
Total operating expenses
၁.၇၂ ကုဋေ
၂.၀၄ ကုဋေ
၂.၀၁ ကုဋေ
၁.၈၅ ကုဋေ
Operating income
-၁.၅၉ ကုဋေ
-၂.၀၄ ကုဋေ
-၂.၀၁ ကုဋေ
-၁.၈၅ ကုဋေ
Other non operating income
၉.၉၀ သိန်း
-
-
-
EBT including unusual items
-၄.၉၄ ကုဋေ
-၁.၉၅ ကုဋေ
-၁.၈၈ ကုဋေ
-၁.၇၃ ကုဋေ
EBT excluding unusual items
-၁.၄၉ ကုဋေ
-၁.၉၅ ကုဋေ
-၁.၈၈ ကုဋေ
-၁.၇၃ ကုဋေ
Income tax expense
၆.၃၆ သိန်း
၉.၅၀ သောင်း
၁.၀၈ သိန်း
၂.၆၀ သိန်း
Effective tax rate
-၁.၂၉%
-၀.၄၉%
-၀.၅၇%
-၁.၅၀%
Other operating expenses
-
-
-
-
Net income
-၅.၀၀ ကုဋေ
-၁.၉၆ ကုဋေ
-၁.၈၉ ကုဋေ
-၁.၇၅ ကုဋေ
Net profit margin
-၃,၈၇၃.၂၂%
-
-
-
Earnings per share
-၁.၆၅
-၁.၆၉
-၁.၀၇
-၀.၉၈
Interest and investment income
-
၉.၀၆ သိန်း
၁.၃၀ သန်း
၁.၁၇ သန်း
Interest expense
-
-
-
-
Net interest expenses
-
၉.၀၆ သိန်း
၁.၃၀ သန်း
၁.၁၇ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၅၂ ကုဋေ
-၂.၀၁ ကုဋေ
-၁.၉၇ ကုဋေ
-၁.၈၁ ကုဋေ
Gain or loss from assets sale
-၁.၈၀ သောင်း
-
-
၇.၀၀ ထောင်
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ